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104 Molecular analysis of diversity within the genus Pseudomonas in
the lungs of cystic ﬁbrosis patients
T. Spasenovski1, G.B. Rogers1, M.P. Carroll2, K.D. Bruce1. 1Molecular
Microbiology Lab, King’s College London, London, United Kingdom; 2Cystic
Fibrosis Unit, Southampton University Hospitals, Southampton, United Kingdom
Pseudomonas spp., especially P. aeruginosa, are important human pathogens and
have been considered to be signiﬁcant in the lung infections that Cystic Fibrosis
(CF) patients suffer. Current methodologies that rely on in vitro cultivation of
bacteria prior to analysis are either too cumbersome or lack sufﬁcient discriminatory
power to be able to deﬁne the diversity of Pseudomonas spp. in CF lung. This
study was undertaken to differentiate species of the genus Pseudomonas by using
a culture-independent molecular biological approach. This assesses the sequence
diversity of the 16S-23S rDNA Internal Transcribed Spacer region 1 (ITS1) of the
Pseudomonas species present in DNA extracted directly from CF sputum samples.
In addition to the relevant controls, ampliﬁcation of the ITS1 region was performed
using 40 sputum samples. Pseudomonas spp. were detected in 75% of samples
tested, including ﬁve samples from which no Pseudomonas spp. had been detected
by conventional culture-based microbiological techniques. Following sequencing of
individual clones, in silico analysis showed that most had the highest homology to
the ITS1 region of P. aeruginosa. To allow a more rapid assessment, a Terminal
Restriction Fragment Length Polymorphism (T-RFLP) based assay was devised
for these PCR products. All the T-RFLP proﬁles obtained for this study set were
indistinguishable from that generated for P. aeruginosa. The signiﬁcance of these
ﬁndings in relation to the wider bacterial community and clinical status of these
patients is discussed.
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Study Consortium study
E. Johansson1, C. Welinder-Olsson1, A. Lindblad2, M. Gilljam2, M. Johannesson3,
P. Meyer4, L. Hjelte5, F. Karpati5. 1Bacteriological laboratory, Go¨teborg, Sweden;
2CF Centre, Sahlgrenska Univ Hosp, Go¨teborg, Sweden; 3Univ Hosp, Uppsala,
Sweden; 4Univ Hosp, Lund, Sweden; 5Karolinska Univ Hosp Huddinge, Stockholm,
Sweden
Objectives: Cystic ﬁbrosis (CF) patients are often colonized with Pseudomonas
aeruginosa (P.a.) and the majority by a strain acquired from the environment.
Reports about cross-infection at CF Centres and camps have led to recommendations
about segregation and regular microbiological surveillance. We aimed to conduct
the ﬁrst surveillance by genomic ﬁngerprinting of P.a. isolates from all four Swedish
CF Centres. More than 350 P.a. isolates from 208 CF patients were analyzed.
Method: P.a. isolates were genotyped using PFGE and the results were conﬁrmed
by MLVA and compared with a French P.a. collection.
Conclusions: Mainly unique strains for each patient were found. Clusters with
strains shared by more than ﬁve patients were only found for B-, J- and X strains,
which has been found in 22%, 14% and 5%, respectively. The B-strain is probably
a common P.a. in the environment and has been isolated from patients in all four
centres. Some strains have been isolated in both Sweden and France. The J-strain is
shared by a few patients in three of four centres with indication of cross-infection
at a camp. The B and X strains are assumed to be common in the environment,
while the J-strain is multiresistant and probably more transmissible. The Swedish
segregation routines seemed to have prevented frequent clustering and patient to
patient transmission until 2004, except for patients attending a camp.
The SCFSC is supported by an unrestricted grant from Solvay Pharma in Denmark,
Norway and Sweden.
106 Development of a diagnostic multiplex PCR test for the
identiﬁcation of three CF epidemic strains of Pseudomonas
aeruginosa
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A number of CF epidemic strains of Pseudomonas aeruginosa have been reported
in Europe and Australia, including the Liverpool epidemic strain (LES) and the
Manchester epidemic strain (MES). A survey of CF centres in England and Wales
showed that the LES was the most common clone amongst CF isolates (11% of all
isolates), followed by the Midlands1 (Mid1) epidemic strain. Small clusters of the
MES were also observed. Individual PCR ampliﬁcation tests have been developed
previously for the LES, Mid1 and MES.
We have developed a simple diagnostic multiplex PCR test that can be used routinely
in laboratories on boiled suspensions of bacteria isolated from sputum. The test
includes markers for the LES, Mid1 and MES strains and a 16S rRNA gene bacterial
control.
In order to evaluate the test, we have screened collections of LES, MES and
Mid1 isolates identiﬁed previously using pulsed ﬁeld gel electrophoresis, along with
various CF and non-CF non-epidemic P. aeruginosa strains. Since it is important
to keep CF patients free from P. aeruginosa infection for as long as possible, it is
necessary to monitor CF patients for the presence of possible transmissible strains.
A simple PCR test should prove to be a useful tool for better informing clinicians
charged with the responsibility for making decisions about segregation in order to
prevent epidemic spread of P. aeruginosa strains amongst patients.
This work was undertaken under the framework of the UK CF Microbiology
Consortium, an initiative funded by the Big Lottery Fund in association with the
Cystic Fibrosis Trust.
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We compared blood agar, McConkey agar, cetrimide agar, cetrimide broth, Pseu-
domonas selective agar, Pseudomonas minimal medium for the detection of
P. aeruginosa from a serial ﬁvefold dilution of P. aeruginosa positive sputa into
P. aeruginosa negative sputa.
On the same serial dilution series we compared the QiaGen Tissue kit, Roche High
Pure PCR Template Preparation kit, Roche MTB DNA extraction kit, Whatman
DNA Extraction Paper and Looxster DNA Extraction kit for use of the puriﬁed
DNA in a P. aeruginosa OprD gene speciﬁc PCR and nested PCR.
The most sensitive culture approach was found to be cetrimide broth incubation
during 24 hours and subsequent plating onto blood agar. The Roche High Pure
PCR kit was found superior to the other techniques for DNA extraction and in
combination with nested PCR a further two steps of the serial dilution (i.e. a 25 fold
dilution) became positive compared to cetrimide broth culture based detection.
